These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
520 related articles for article (PubMed ID: 33928870)
1. In a search for potential drug candidates for combating COVID-19: computational study revealed salvianolic acid B as a potential therapeutic targeting 3CLpro and spike proteins. Elmaaty AA; Darwish KM; Khattab M; Elhady SS; Salah M; Hamed MIA; Al-Karmalawy AA; Saleh MM J Biomol Struct Dyn; 2022; 40(19):8866-8893. PubMed ID: 33928870 [TBL] [Abstract][Full Text] [Related]
2. Evaluation of apigenin-based biflavonoid derivatives as potential therapeutic agents against viral protease (3CLpro) of SARS-CoV-2 via molecular docking, molecular dynamics and quantum mechanics studies. Abdizadeh R; Hadizadeh F; Abdizadeh T J Biomol Struct Dyn; 2023; 41(13):5915-5945. PubMed ID: 35848354 [TBL] [Abstract][Full Text] [Related]
3. Computational Search for Potential COVID-19 Drugs from Ayurvedic Medicinal Plants to Identify Potential Inhibitors against SARS-CoV-2 Targets. Alagarsamy V; Solomon VR; Sundar PS; Kulkarni VS; Sulthana MT; Aishwarya AD; Narendhar B; Murugesan S Curr Comput Aided Drug Des; 2023; 19(1):51-67. PubMed ID: 36424783 [TBL] [Abstract][Full Text] [Related]
4. Computational identification of potential inhibitory compounds in Indian medicinal and aromatic plant species against major pathogenicity determinants of SARS-CoV-2. Sharma S; Sharma A; Bhattacharyya D; Chauhan RS J Biomol Struct Dyn; 2022; 40(24):14096-14114. PubMed ID: 34766880 [TBL] [Abstract][Full Text] [Related]
5. Cameroonian medicinal plants as potential candidates of SARS-CoV-2 inhibitors. Fouedjou RT; Chtita S; Bakhouch M; Belaidi S; Ouassaf M; Djoumbissie LA; Tapondjou LA; Abul Qais F J Biomol Struct Dyn; 2022; 40(19):8615-8629. PubMed ID: 33908318 [TBL] [Abstract][Full Text] [Related]
6. In silico analysis and identification of antiviral coumarin derivatives against 3-chymotrypsin-like main protease of the novel coronavirus SARS-CoV-2. Abdizadeh R; Hadizadeh F; Abdizadeh T Mol Divers; 2022 Apr; 26(2):1053-1076. PubMed ID: 34213728 [TBL] [Abstract][Full Text] [Related]
7. Exploring the Binding Effects of Natural Products and Antihypertensive Drugs on SARS-CoV-2: An In Silico Investigation of Main Protease and Spike Protein. Moschovou K; Antoniou M; Chontzopoulou E; Papavasileiou KD; Melagraki G; Afantitis A; Mavromoustakos T Int J Mol Sci; 2023 Nov; 24(21):. PubMed ID: 37958877 [TBL] [Abstract][Full Text] [Related]
8. Plant-derived active compounds as a potential nucleocapsid protein inhibitor of SARS-CoV-2: an Kashyap D; Roy R; Kar P; Jha HC J Biomol Struct Dyn; 2023 Jul; 41(10):4770-4785. PubMed ID: 35532092 [TBL] [Abstract][Full Text] [Related]
9. [Salvianolic acid B and its magnesium salt inhibit SARS-CoV-2 infection of Vero-E6 cells by blocking spike protein-mediated membrane fusion]. Yang C; Cheng C; Wang J; Chen K; Zhan J; Pan X; Xu X; Xu W; Liu S Nan Fang Yi Ke Da Xue Xue Bao; 2021 Apr; 41(4):475-482. PubMed ID: 33963705 [TBL] [Abstract][Full Text] [Related]
10. Plant derived active compounds as potential anti SARS-CoV-2 agents: an Kashyap D; Jakhmola S; Tiwari D; Kumar R; Moorthy NSHN; Elangovan M; Brás NF; Jha HC J Biomol Struct Dyn; 2022; 40(21):10629-10650. PubMed ID: 34225565 [TBL] [Abstract][Full Text] [Related]
11. Plant-Derived Antiviral Compounds as Potential Entry Inhibitors against Spike Protein of SARS-CoV-2 Wild-Type and Delta Variant: An Integrative in SilicoApproach. Ambrose JM; Kullappan M; Patil S; Alzahrani KJ; Banjer HJ; Qashqari FSI; Raj AT; Bhandi S; Veeraraghavan VP; Jayaraman S; Sekar D; Agarwal A; Swapnavahini K; Krishna Mohan S Molecules; 2022 Mar; 27(6):. PubMed ID: 35335139 [TBL] [Abstract][Full Text] [Related]
12. Antiviral activity of traditional medicinal plants from Ayurveda against SARS-CoV-2 infection. Maurya VK; Kumar S; Bhatt MLB; Saxena SK J Biomol Struct Dyn; 2022 Mar; 40(4):1719-1735. PubMed ID: 33073699 [TBL] [Abstract][Full Text] [Related]
13. Traditional medicinal plants against replication, maturation and transmission targets of SARS-CoV-2: computational investigation. Mondal P; Natesh J; Abdul Salam AA; Thiyagarajan S; Meeran SM J Biomol Struct Dyn; 2022 Apr; 40(6):2715-2732. PubMed ID: 33150860 [TBL] [Abstract][Full Text] [Related]
14. Anisotine and amarogentin as promising inhibitory candidates against SARS-CoV-2 proteins: a computational investigation. Kar P; Kumar V; Vellingiri B; Sen A; Jaishee N; Anandraj A; Malhotra H; Bhattacharyya S; Mukhopadhyay S; Kinoshita M; Govindasamy V; Roy A; Naidoo D; Subramaniam MD J Biomol Struct Dyn; 2022 Jul; 40(10):4532-4542. PubMed ID: 33305988 [TBL] [Abstract][Full Text] [Related]
15. Discovery of putative inhibitors against main drivers of SARS-CoV-2 infection: Insight from quantum mechanical evaluation and molecular modeling. Balogun TA; Chukwudozie OS; Ogbodo UC; Junaid IO; Sunday OA; Ige OM; Aborode AT; Akintayo AD; Oluwarotimi EA; Oluwafemi IO; Saibu OA; Chuckwuemaka P; Omoboyowa DA; Alausa AO; Atasie NH; Ilesanmi A; Dairo G; Tiamiyu ZA; Batiha GE; Alkhuriji AF; Al-Megrin WAI; De Waard M; Sabatier JM Front Chem; 2022; 10():964446. PubMed ID: 36304744 [TBL] [Abstract][Full Text] [Related]
16. Marine algal antagonists targeting 3CL protease and spike glycoprotein of SARS-CoV-2: a computational approach for anti-COVID-19 drug discovery. Arunkumar M; Gunaseelan S; Kubendran Aravind M; Mohankumar V; Anupam P; Harikrishnan M; Siva A; Ashokkumar B; Varalakshmi P J Biomol Struct Dyn; 2022; 40(19):8961-8988. PubMed ID: 34014150 [TBL] [Abstract][Full Text] [Related]
17. Targeting the 3CLpro and RdRp of SARS-CoV-2 with phytochemicals from medicinal plants of the Andean Region: molecular docking and molecular dynamics simulations. Mosquera-Yuqui F; Lopez-Guerra N; Moncayo-Palacio EA J Biomol Struct Dyn; 2022 Mar; 40(5):2010-2023. PubMed ID: 33084512 [TBL] [Abstract][Full Text] [Related]
18. Structure-based virtual screening, molecular dynamics and binding affinity calculations of some potential phytocompounds against SARS-CoV-2. Naik SR; Bharadwaj P; Dingelstad N; Kalyaanamoorthy S; Mandal SC; Ganesan A; Chattopadhyay D; Palit P J Biomol Struct Dyn; 2022 Sep; 40(15):6921-6938. PubMed ID: 33682632 [TBL] [Abstract][Full Text] [Related]
20. In silico ADMET and molecular docking study on searching potential inhibitors from limonoids and triterpenoids for COVID-19. Vardhan S; Sahoo SK Comput Biol Med; 2020 Sep; 124():103936. PubMed ID: 32738628 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]